Literature DB >> 1970592

The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.

T Shirai1, M Abe, H Yagita, K Okumura, H C Morse, W F Davidson.   

Abstract

Mice homozygous for either of two autosomal recessive mutations, lpr and gld, develop massive, generalized lymphoproliferation of CD4-CD8- (double negative, DN) T cells associated with a variety of autoantibodies. To determine the origin of these expanded populations of lpr and gld T cells, we examined the expression of CD2 molecules and mRNA transcripts in association with other cell surface phenotypes of these cells and correlated them with subpopulations of DN T cells in the thymus and peripheral lymphoid tissues. The results indicated that both lpr and gld cells are negative for the transcript and product of the CD2 gene. Both lpr and gld DN T cells were CD2-, CD3+, CD4-, CD8-, CD25-, CD45R+, TCR alpha/beta+, TCR gamma/delta-, HSA(J11d)-/+, Thy-1+/-, and Lp-1-/+. Studies of thymocytes in normal mice using three-color flow cytometry analysis showed that there are at least eight phenotypically distinct populations of DN thymocytes, one of which is similar to lpr and gld cells in terms of CD2-, CD3+, TCR alpha/beta+ and CD25- phenotypes, although they did not express CD45R, HSA, or Lp-1. A very minor population of these CD2-CD3+ TCR alpha/beta+ DN T cells were also detected in peripheral T cells from normal mice. These findings may provide insight into not only the origin of the aberrant lpr and gld T cells but also normal T cell development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970592

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.

Authors:  Brian D Hondowicz; Michele L Fields; Simone A Nish; Joseph Larkin; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

2.  Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice.

Authors:  K Ohl; A Wiener; A Schippers; N Wagner; K Tenbrock
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

Review 3.  Double negative (DN) αβ T cells: misperception and overdue recognition.

Authors:  Maria N Martina; Sanjeev Noel; Ankit Saxena; Hamid Rabb; Abdel Rahim A Hamad
Journal:  Immunol Cell Biol       Date:  2014-11-25       Impact factor: 5.126

4.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity.

Authors:  Shahnawaz Imam; Rodis Paparodis; Deepak Sharma; Juan Carlos Jaume
Journal:  Endocr Relat Cancer       Date:  2014-03-12       Impact factor: 5.678

Review 6.  Double-negative T cells in autoimmune diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 4.941

7.  Heterogeneity and biased T cell receptor alpha/beta repertoire of mucosal CD8+ cells from murine large intestine: implications for functional state.

Authors:  A R Ibraghimov; R G Lynch
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.